Desong Zhong

High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): A high-affinity 5-HT2A receptor-selective agonist radioligand

David E. Nichols, Stewart Frescas, Benjamin R. Chemel et al. · Bioorganic & Medicinal Chemistry · 2008 · 65 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +10

Synthesis and Pharmacological Characterization of [¹²⁵I]Iodomethyllycaconitine ([¹²⁵I]Iodo-MLA). A New Ligand for the α₇Nicotinic Acetylcholine Receptor

Hernán A. Navarro, Desong Zhong, Philip Abraham et al. · Journal of Medicinal Chemistry · 2000 · 32 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

In vitro and in vivo characterization of [¹²⁵I]iodomethyllycaconitine in the rat

Hernán A. Navarro, H. Eric Xu, Desong Zhong et al. · Synapse · 2002 · 22 citations

Medicine, Pharmacokinetics, Pharmacology +6

Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1<i>S</i>,3a<i>S</i>)-2,3,3a,4,5,6-Hexahydro-1<i>H</i>-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198)

Steven D. Chang, Lawrence E. Brieaddy, Joseph D. Harvey et al. · ACS Chemical Neuroscience · 2015 · 17 citations

Medicine, Medicinal Chemistry, Pharmacology +17

A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay

Emilie D. Smith, N. Ariane Vinson, Desong Zhong et al. · Bioorganic & Medicinal Chemistry · 2007 · 10 citations

Medicine, Medicinal Chemistry, Pharmacology +6